| Revenue growth | 20% YoY for FY2026 |
|---|---|
| Margins | EBITDA margins at 24.2% consolidated; 25.7% excluding Noida. |
| Demand visibility | Strong; in-patient count up 16%, out-patient up 18.7%. |
| Management confidence | High; citing robust volume growth and capacity expansion. |
Growth
FY26 Revenue: ₹45,089mn (+19.6% YoY); PAT: ₹5,541mn (+15.1% YoY); EBITDA (ex-Noida) margin: 25.7%.
Outlook
Capex of ₹9,400mn in FY26. Planned 400-bed hospitals in Guwahati and Varanasi; 80-bed Indore cancer unit operational in Q2 FY27.
Risks
Startup losses at Medanta Noida (₹783mn EBITDA loss in FY26); flight disruptions affecting international patient volumes in Q4.
Earnings Call filed with NSE, NSE: MEDANTA. Summary written with AI assistance from the document.
Global Health Ltd: key numbers
- Share price
- ₹1,294.10
- Market cap
- ₹34,795 Cr
- Revenue (annual)
- ₹4,410 Cr
- Net profit (annual)
- ₹556.5 Cr
- P/E (TTM)
- 62.6×Sector 53.1×
- Promoter holding
- 33.00%-0.01% QoQ
- FII holding
- 9.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Global Health Ltd
All →Global Health Employee Stock Options
Global Health Limited has allotted equity shares under its ESOP/ESPS scheme. This action results in a minor increase in the company's total paid-up share capital.
Global Health Employee Stock Options
Global Health Limited has allotted 3,000 equity shares under its employee stock option plan at a premium of Rs. 1,498 per share.
- Value
- ₹0.45 Cr
Global Health Annual General Meeting
Global Health Limited held its 22nd Annual General Meeting on September 16, 2026. The meeting covered financial statement adoption and shareholder dividend declaration.
Global Health Other Announcement
Global Health Limited has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 as mandated by SEBI (LODR) regulations.
Global Health Annual General Meeting
Global Health Limited has announced its 22nd Annual General Meeting to be held on September 16, 2026, to consider financial statements, dividends, and director re-appointment.
- Value
- ₹0.12 Cr
Global Health Annual Report
Global Health Limited has submitted its Annual Report for the financial year 2025-26, alongside the notice for its 22nd Annual General Meeting.